Abiopharma

🔍 Sennesael Kris (Executive)

Company: WESTERN DIGITAL CORP (WDC)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 8,274 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 178,007.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 19 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 178,026.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 4,317 shares of Common Stock at $468.88 per share (Direct)
  Date: 2026-08-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 173,709.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 20 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 444.32 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Represents the grant of restricted stock units to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
• F2: The dividend equivalent rights were converted into, and paid in the form of, shares of the Issuer's common stock on a one-for-one basis in connection with the vesting of restricted stock units to which the dividend equivalent rights relate. A cash amount was also paid to the holder to settle a fractional dividend equivalent right.
• F3: Payment of tax obligation by withholding securities incident to the vesting of securities in accordance with Rule 16b-3(e).